Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Once reconstituted into a suitable solution or cosmetic base, the peptide can be applied as part of a targeted routine
Separation anxiety in dogs: What progress has been made in our understanding of the most common behavioral problems in dogs
Regulation and boundary between cosmetic, medical device and medicine In Europe, topical peptides fall under three distinct regulatory frameworks according to their claim and mechanism: Cosmetic (EC Regulation 1223/2009) Surface cutaneous action, beauty and hygiene claims No therapeutic claim authorised Product information file (PIF), safety evaluation Examples: Matrixyl, Argireline, Pal-GHK in anti-ageing serums Medical device (EU Regulation 2017/745) Main physical/mechanical action, medical claim Classes I, IIa, IIb, III according to risk CE marking mandatory, notified bodies for class IIa+ Example: GHK-Cu dressings for wound healing Medicine (Directive 2001/83/EC) Explicit therapeutic claim, pharmacological action MA mandatory (EMA or national agencies), phase I-III clinical trials Example: Afamelanotide for erythropoietic protoporphyria (MA 2014) This segmentation has direct implications for research : a molecule can change regulatory status according to its final formulation and claims
Explore the GHK-Cu research peptide for your laboratory applications, and consult our full peptide sciences research guide for the broader scientific framework
PloS One 11, e0167295
US$ 26.44
US$ 27.95
US$ 22.23
US$ 29.38
US$ 23.28
US$ 28.05
US$ 20.34
US$ 28.16
US$ 21.59
US$ 23.79
US$ 27.31
US$ 23.21
US$ 24.79
US$ 24.86
US$ 23.33
US$ 27.28
US$ 29.96